Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.75    -0.375 (-2.65%)
Bid:
13.50
Ask:
14.00
Spread: 0.50 (3.704%)
Market Cap: £61.76m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Holding(s) in Company

1 Dec 2022 14:12

RNS Number : 3111I
Creo Medical Group PLC
01 December 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BZ1BLL44

Issuer Name

CREO MEDICAL GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Baillie Gifford & Co

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

30-Nov-2022

6. Date on which Issuer notified

01-Dec-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.998000

0.000000

4.998000

9073739

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BZ1BLL44

9073739

4.998000

Sub Total 8.A

9073739

4.998000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Baillie Gifford & Co

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

01-Dec-2022

13. Place Of Completion

Edinburgh

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEALAFEFFAFFA
Date   Source Headline
5th Apr 20197:00 amRNSFinal Results
28th Mar 20197:00 amRNSUpdate on US Clinical Education Programme
21st Mar 20192:34 pmRNSExercise of Options
21st Mar 20197:00 amRNSNotice of results and investor briefing
18th Mar 20197:00 amRNSCreo founder in Sunday Times 100 UK entrepreneurs
14th Mar 20195:17 pmRNSHolding(s) in Company
12th Mar 20199:19 amRNSSpeedboat in BSG Endoscopy best video abstract
6th Mar 201912:58 pmRNSExercise of Options
11th Feb 20197:00 amRNSDistribution agreement for France, Germany, Italy
24th Jan 201911:17 amRNSGrowth & Innovation Forum 2019
16th Jan 20197:00 amRNSFirst use of Speedboat in the US
17th Dec 20184:28 pmRNSExercise of Options
3rd Dec 20187:00 amRNSFirst placement and use of Speedboat in Europe
23rd Nov 201810:43 amRNSDirector/PDMR Shareholding
19th Nov 20181:30 pmRNSExercise of Options
22nd Oct 20182:52 pmRNSHolding(s) in Company
19th Oct 20187:00 amRNSUK Endoscopy Training Course
17th Oct 20187:00 amRNSSpain & Benelux Framework Distribution Agreements
12th Oct 20187:00 amRNSHolding(s) in Company
8th Oct 20187:00 amRNSInvestor Open Event at Chepstow
3rd Oct 201812:14 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim results for six months ended 30 June 2018
17th Sep 20187:04 amRNSExtension of Distribution Agreement with Pentax
13th Sep 20187:00 amRNSFirst use of Speedboat in South Africa
3rd Sep 20181:34 pmRNSHolding(s) in Company
31st Aug 201811:32 amRNSHolding(s) in Company
31st Aug 201811:30 amRNSDirector/PDMR Shareholding
21st Aug 20183:59 pmRNSIssue of Equity Update - Amendment
21st Aug 20181:48 pmRNSIssue of Equity Update
20th Aug 201810:13 amRNSDirector/PDMR Shareholding
1st Aug 20181:24 pmRNSResult of General Meeting
18th Jul 20184:44 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSConditional Placing of New Ordinary Shares
9th Jul 20187:00 amRNSAgreement with First Medical Company
4th Jul 20187:00 amRNSUK Distribution Agreement with Diagmed Healthcare
2nd Jul 20187:00 amRNSMarket Update
10th May 201811:25 amRNSExercise of Options
20th Apr 20184:38 pmRNSChange of accounting reference date
20th Mar 20187:00 amRNSInterim results for six months to 31 December 2017
28th Feb 20184:32 pmRNSChange of Registered Office
12th Feb 20187:00 amRNSExercise of Options
9th Jan 20185:43 pmRNSDirector/PDMR Shareholding
22nd Dec 201712:10 pmRNSDirector/PDMR Shareholding
22nd Dec 20179:24 amRNSDirector/PDMR Shareholding
20th Dec 20171:32 pmRNSResult of AGM
29th Nov 20177:00 amRNSSpeedboat RS2 advances beyond initial pilot centre
24th Nov 201710:49 amRNSNotice of AGM
14th Nov 20177:00 amRNSFinal Results
25th Sep 20173:07 pmRNSHolding(s) in Company
18th Sep 20179:56 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.